176 related articles for article (PubMed ID: 18520636)
21. Potential role of direct adenoviral gene transfer in enhancing fracture repair.
Baltzer AW; Lattermann C; Whalen JD; Ghivizzani S; Wooley P; Krauspe R; Robbins PD; Evans CH
Clin Orthop Relat Res; 2000 Oct; (379 Suppl):S120-5. PubMed ID: 11039760
[TBL] [Abstract][Full Text] [Related]
22. Comparison of human mesenchymal stem cells derived from adipose tissue and bone marrow for ex vivo gene therapy in rat spinal fusion model.
Miyazaki M; Zuk PA; Zou J; Yoon SH; Wei F; Morishita Y; Sintuu C; Wang JC
Spine (Phila Pa 1976); 2008 Apr; 33(8):863-9. PubMed ID: 18404105
[TBL] [Abstract][Full Text] [Related]
23. Influence of short-term adenoviral vector and prolonged lentiviral vector mediated bone morphogenetic protein-2 expression on the quality of bone repair in a rat femoral defect model.
Virk MS; Conduah A; Park SH; Liu N; Sugiyama O; Cuomo A; Kang C; Lieberman JR
Bone; 2008 May; 42(5):921-31. PubMed ID: 18295562
[TBL] [Abstract][Full Text] [Related]
24. Adenovirus-mediated direct gene therapy with bone morphogenetic protein-2 produces bone.
Musgrave DS; Bosch P; Ghivizzani S; Robbins PD; Evans CH; Huard J
Bone; 1999 Jun; 24(6):541-7. PubMed ID: 10375195
[TBL] [Abstract][Full Text] [Related]
25. Genetic enhancement of fracture repair: healing of an experimental segmental defect by adenoviral transfer of the BMP-2 gene.
Baltzer AW; Lattermann C; Whalen JD; Wooley P; Weiss K; Grimm M; Ghivizzani SC; Robbins PD; Evans CH
Gene Ther; 2000 May; 7(9):734-9. PubMed ID: 10822299
[TBL] [Abstract][Full Text] [Related]
26. Liver toxicities typically induced by first-generation adenoviral vectors can be reduced by use of E1, E2b-deleted adenoviral vectors.
Everett RS; Hodges BL; Ding EY; Xu F; Serra D; Amalfitano A
Hum Gene Ther; 2003 Dec; 14(18):1715-26. PubMed ID: 14670123
[TBL] [Abstract][Full Text] [Related]
27. Enhancement of spine fusion using combined gene therapy and tissue engineering BMP-7-expressing bone marrow cells and allograft bone.
Hidaka C; Goshi K; Rawlins B; Boachie-Adjei O; Crystal RG
Spine (Phila Pa 1976); 2003 Sep; 28(18):2049-57. PubMed ID: 14501913
[TBL] [Abstract][Full Text] [Related]
28. Comparative Study of Adeno-associated Virus, Adenovirus, Bacu lovirus and Lentivirus Vectors for Gene Therapy of the Eyes.
Kalesnykas G; Kokki E; Alasaarela L; Lesch HP; Tuulos T; Kinnunen K; Uusitalo H; Airenne K; Yla-Herttuala S
Curr Gene Ther; 2017; 17(3):235-247. PubMed ID: 28982327
[TBL] [Abstract][Full Text] [Related]
29. Sustained delivery of therapeutic concentrations of human clotting factor IX--a comparison of adenoviral and AAV vectors administered in utero.
Schneider H; Mühle C; Douar AM; Waddington S; Jiang QJ; von der Mark K; Coutelle C; Rascher W
J Gene Med; 2002; 4(1):46-53. PubMed ID: 11828387
[TBL] [Abstract][Full Text] [Related]
30. Potential use of Sox9 gene therapy for intervertebral degenerative disc disease.
Paul R; Haydon RC; Cheng H; Ishikawa A; Nenadovich N; Jiang W; Zhou L; Breyer B; Feng T; Gupta P; He TC; Phillips FM
Spine (Phila Pa 1976); 2003 Apr; 28(8):755-63. PubMed ID: 12698117
[TBL] [Abstract][Full Text] [Related]
31. Adenovirus-mediated gene transfer to nucleus pulposus cells. Implications for the treatment of intervertebral disc degeneration.
Nishida K; Kang JD; Suh JK; Robbins PD; Evans CH; Gilbertson LG
Spine (Phila Pa 1976); 1998 Nov; 23(22):2437-42; discussion 2443. PubMed ID: 9836359
[TBL] [Abstract][Full Text] [Related]
32. Modulation of the biologic activity of the rabbit intervertebral disc by gene therapy: an in vivo study of adenovirus-mediated transfer of the human transforming growth factor beta 1 encoding gene.
Nishida K; Kang JD; Gilbertson LG; Moon SH; Suh JK; Vogt MT; Robbins PD; Evans CH
Spine (Phila Pa 1976); 1999 Dec; 24(23):2419-25. PubMed ID: 10626303
[TBL] [Abstract][Full Text] [Related]
33. Effect of BMP-2 gene transfer on bone healing in sheep.
Egermann M; Lill CA; Griesbeck K; Evans CH; Robbins PD; Schneider E; Baltzer AW
Gene Ther; 2006 Sep; 13(17):1290-9. PubMed ID: 16642029
[TBL] [Abstract][Full Text] [Related]
34. Percutaneous spinal fusion using bone morphogenetic protein-2 gene therapy.
Alden TD; Pittman DD; Beres EJ; Hankins GR; Kallmes DF; Wisotsky BM; Kerns KM; Helm GA
J Neurosurg; 1999 Jan; 90(1 Suppl):109-14. PubMed ID: 10413134
[TBL] [Abstract][Full Text] [Related]
35. Bone regeneration in critical size defects by cell-mediated BMP-2 gene transfer: a comparison of adenoviral vectors and liposomes.
Park J; Ries J; Gelse K; Kloss F; von der Mark K; Wiltfang J; Neukam FW; Schneider H
Gene Ther; 2003 Jul; 10(13):1089-98. PubMed ID: 12808439
[TBL] [Abstract][Full Text] [Related]
36. Quantitative analysis of gene expression in a rabbit model of intervertebral disc degeneration by real-time polymerase chain reaction.
Sobajima S; Shimer AL; Chadderdon RC; Kompel JF; Kim JS; Gilbertson LG; Kang JD
Spine J; 2005; 5(1):14-23. PubMed ID: 15653081
[TBL] [Abstract][Full Text] [Related]
37. Adverse effects of adenovirus-mediated gene transfer of human transforming growth factor beta 1 into rabbit knees.
Mi Z; Ghivizzani SC; Lechman E; Glorioso JC; Evans CH; Robbins PD
Arthritis Res Ther; 2003; 5(3):R132-9. PubMed ID: 12723985
[TBL] [Abstract][Full Text] [Related]
38. Repair of articular cartilage defect by intraarticular administration of basic fibroblast growth factor gene, using adeno-associated virus vector.
Hiraide A; Yokoo N; Xin KQ; Okuda K; Mizukami H; Ozawa K; Saito T
Hum Gene Ther; 2005 Dec; 16(12):1413-21. PubMed ID: 16390272
[TBL] [Abstract][Full Text] [Related]
39. Adenoviral and adeno-associated viral vector mediated gene transfer in the guinea pig cochlea.
Li Duan M; Bordet T; Mezzina M; Kahn A; Ulfendahl M
Neuroreport; 2002 Jul; 13(10):1295-9. PubMed ID: 12151790
[TBL] [Abstract][Full Text] [Related]
40. Comparison of adenoviral and adeno-associated viral vectors for pancreatic gene delivery in vivo.
Wang AY; Peng PD; Ehrhardt A; Storm TA; Kay MA
Hum Gene Ther; 2004 Apr; 15(4):405-13. PubMed ID: 15053865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
